Yuliang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuliang Wang has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Nathan Daniel Price
Buck Institute for Research on Aging, Novato, USA
4 shared publications - Hannele Ruohola-Baker
University of Washington
3 shared publications - Jaeyun Sung
Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States
3 shared publications - Stuart J. Shankland
Division of Nephrology, University of Washington, Seattle, Washington
3 shared publications - Andrew T. Magis
Institute for Systems Biology, Seattle, WA 98109, USA
2 shared publications - Arikketh Devi
Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, TamilNadu 603203, India
2 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
Spatially Patterned Podocyte State Transitions Coordinate Aging of the Glomerulus
Key Points: Anatomic zones in the kidney are transcriptionally hardwired. The juxtamedullary region of the kidney is enriched in a podocyte subcluster with an aging, senescent, and inflammatory transcriptional signature. Glomerular communication is preserved across age and anatomic region, but selective ligand–receptor pathways are altered. Background: Glomerular aging is accompanied by podocyte loss, glomerulosclerosis, and declining kidney function, yet the cellular states and intercellular programs underlying these changes remain incompletely defined. Thus, we tested whether aging produces coordinated, cell type–specific transcriptional changes that differ between outer cortical and juxtamedullary nephrons. Methods: Single-nucleus RNA sequencing was performed in micro-dissected outer cortical and juxtamedullary kidney regions from mice aged 4, 20, and 25 months. Region prediction, lineage-specific subclustering, gene set enrichment, trajectory inference, and ligand–receptor analyses were used to define spatially and age-associated kidney cell states and inferred glomerular communication. Results: Analysis of 860,869 nuclei revealed transcriptional identities linked to anatomic region across multiple cell types, including juxtamedullary enrichment of napsin A aspartic peptidase . In proximal tubule, heterogeneity primarily reflected segment and functional state, without age-dependent redistribution. Conversely, in podocytes, 1 of the 5 transcriptionally connected transcriptional states was a stress-adaptive state. It was enriched in the juxtamedullary region and exhibited the greatest aging, senescence, and inflammatory gene set activity. Yet, like parietal epithelial, glomerular endothelial, and mesangial cell states, podocytes showed little compositional remodeling with age. The inferred glomerular communication architecture was largely preserved across age and region, with podocytes having the greatest outgoing and mesangial cells the greatest incoming interaction burden. Aging selectively altered only a limited number of candidate ligand–receptor programs such as juxtamedullary podocyte-to-parietal epithelial cell Egf and lipoprotein lipase signaling. Conclusions: In healthy mice, anatomic location was a stronger determinant than chronologic age. Aging did not produce widespread expansion of discrete aging-associated populations, but instead selectively modified transcriptional and communication programs within an anatomically patterned glomerular landscape. In fact, the juxtamedullary-enriched, stress-associated podocyte state provides a mechanistic explanation for recognized regional-specific glomerular vulnerability.
- 14 September 2026
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
Open AccessSpatially Patterned Podocyte State Transitions Coordinate Aging of the Glomerulus
Key Points: Anatomic zones in the kidney are transcriptionally hardwired. The juxtamedullary region of the kidney is enriched in a podocyte subcluster with an aging, senescent, and inflammatory transcriptional signature. Glomerular communication is preserved across age and anatomic region, but selective ligand–receptor pathways are altered. Background: Glomerular aging is accompanied by podocyte loss, glomerulosclerosis, and declining kidney function, yet the cellular states and intercellular programs underlying these changes remain incompletely defined. Thus, we tested whether aging produces coordinated, cell type–specific transcriptional changes that differ between outer cortical and juxtamedullary nephrons. Methods: Single-nucleus RNA sequencing was performed in micro-dissected outer cortical and juxtamedullary kidney regions from mice aged 4, 20, and 25 months. Region prediction, lineage-specific subclustering, gene set enrichment, trajectory inference, and ligand–receptor analyses were used to define spatially and age-associated kidney cell states and inferred glomerular communication. Results: Analysis of 860,869 nuclei revealed transcriptional identities linked to anatomic region across multiple cell types, including juxtamedullary enrichment of napsin A aspartic peptidase . In proximal tubule, heterogeneity primarily reflected segment and functional state, without age-dependent redistribution. Conversely, in podocytes, 1 of the 5 transcriptionally connected transcriptional states was a stress-adaptive state. It was enriched in the juxtamedullary region and exhibited the greatest aging, senescence, and inflammatory gene set activity. Yet, like parietal epithelial, glomerular endothelial, and mesangial cell states, podocytes showed little compositional remodeling with age. The inferred glomerular communication architecture was largely preserved across age and region, with podocytes having the greatest outgoing and mesangial cells the greatest incoming interaction burden. Aging selectively altered only a limited number of candidate ligand–receptor programs such as juxtamedullary podocyte-to-parietal epithelial cell Egf and lipoprotein lipase signaling. Conclusions: In healthy mice, anatomic location was a stronger determinant than chronologic age. Aging did not produce widespread expansion of discrete aging-associated populations, but instead selectively modified transcriptional and communication programs within an anatomically patterned glomerular landscape. In fact, the juxtamedullary-enriched, stress-associated podocyte state provides a mechanistic explanation for recognized regional-specific glomerular vulnerability.
- Open Access
Genome-scale metabolic model predicts mechanistic differences in metabolic gradient of spatially resolved small intestine villi
Studying the spatial metabolic gradient provides significant opportunities for understanding the spatial division of labor within the tissue microenvironment. Enterocytes have the capacity to perform serial oxidation and conjugation reactions for detoxification, making the small intestine important as one of the first-pass metabolic organs. Recently, the enterocyte metabolic gradient was found to exhibit differential metabolic preferences depending on its location in the villus. However, it remains unclear how metabolism mechanistically differs in enterocyte microenvironments. To bridge this knowledge gap, we leveraged spatial transcriptomics data to (1) reconstruct genome-scale metabolic networks (GSMMs) that are location-specific, and (2) identify metabolic genes that may explain the differential susceptibility of different villus sections to diseases, diet, and other factors. We found that enterocytes at the bottom of the villus are enriched in genes related to intermediary metabolism, phase-I and -II metabolism, bile acid metabolism, and transporters. Comparing enterocyte GSMMs between the top and bottom of villi, we show that enterocytes at the top produce NAD and threonine more robustly compared to bottom enterocytes. Conversely, bottom enterocytes produce guanosine monophosphate (GMP) more readily than enterocytes at the top of the villus. These metabolic differences may have implications for differential villi susceptibility to diseases such as neuroendocrine tumors, acute graft-versus-host disease, and nutritional perturbations such as high-fat diets. Taken together, our findings demonstrate in a mechanistic manner the metabolic differences of enterocytes in the small intestine, providing information that can be applied to additional disease states and inform therapeutics development. AUTHOR SUMMARY: Significant metabolic gradients exist across different locations in a cell. Currently, bulk expression experiments, used in most animal studies and clinical trials, fail to describe this spatial variation due to the averaging effect in the tissue of interest. Recently, single-cell RNA sequencing technologies revealed heterogeneity within tissues. However, the underlying differences and mechanisms for the spatial metabolic variations remain understudied. In this research, we focus on the small intestine, which plays a critical role in nutrient absorption, distribution, and drug metabolism. The walls of the small intestine are composed of finger-like projections, called villi , that are composed of enterocytes. To investigate the potential mechanism underlying metabolic differences of enterocytes along the villi, we built and compared networks formed by gene-protein reaction relationships from spatially resolved bulk and scRNA-seq data. We found that enterocytes at the villus top more robustly produced key components in cell metabolism, such as nicotinamide adenine dinucleotide (nad) and threonine, whereas enterocytes at the villus bottom more robustly produced the nucleotide guanosine monophosphate (GMP). Our approach can be extended to the study of metabolic differences in other organs and diseases and to research the metabolism of specific compounds.
Open AccessGenome-scale metabolic model predicts mechanistic differences in metabolic gradient of spatially resolved small intestine villi
Studying the spatial metabolic gradient provides significant opportunities for understanding the spatial division of labor within the tissue microenvironment. Enterocytes have the capacity to perform serial oxidation and conjugation reactions for detoxification, making the small intestine important as one of the first-pass metabolic organs. Recently, the enterocyte metabolic gradient was found to exhibit differential metabolic preferences depending on its location in the villus. However, it remains unclear how metabolism mechanistically differs in enterocyte microenvironments. To bridge this knowledge gap, we leveraged spatial transcriptomics data to (1) reconstruct genome-scale metabolic networks (GSMMs) that are location-specific, and (2) identify metabolic genes that may explain the differential susceptibility of different villus sections to diseases, diet, and other factors. We found that enterocytes at the bottom of the villus are enriched in genes related to intermediary metabolism, phase-I and -II metabolism, bile acid metabolism, and transporters. Comparing enterocyte GSMMs between the top and bottom of villi, we show that enterocytes at the top produce NAD and threonine more robustly compared to bottom enterocytes. Conversely, bottom enterocytes produce guanosine monophosphate (GMP) more readily than enterocytes at the top of the villus. These metabolic differences may have implications for differential villi susceptibility to diseases such as neuroendocrine tumors, acute graft-versus-host disease, and nutritional perturbations such as high-fat diets. Taken together, our findings demonstrate in a mechanistic manner the metabolic differences of enterocytes in the small intestine, providing information that can be applied to additional disease states and inform therapeutics development. AUTHOR SUMMARY: Significant metabolic gradients exist across different locations in a cell. Currently, bulk expression experiments, used in most animal studies and clinical trials, fail to describe this spatial variation due to the averaging effect in the tissue of interest. Recently, single-cell RNA sequencing technologies revealed heterogeneity within tissues. However, the underlying differences and mechanisms for the spatial metabolic variations remain understudied. In this research, we focus on the small intestine, which plays a critical role in nutrient absorption, distribution, and drug metabolism. The walls of the small intestine are composed of finger-like projections, called villi , that are composed of enterocytes. To investigate the potential mechanism underlying metabolic differences of enterocytes along the villi, we built and compared networks formed by gene-protein reaction relationships from spatially resolved bulk and scRNA-seq data. We found that enterocytes at the villus top more robustly produced key components in cell metabolism, such as nicotinamide adenine dinucleotide (nad) and threonine, whereas enterocytes at the villus bottom more robustly produced the nucleotide guanosine monophosphate (GMP). Our approach can be extended to the study of metabolic differences in other organs and diseases and to research the metabolism of specific compounds.
- Open Access
Human iPSC Derived Enamel Organoid Guided by Single-Cell Atlas of Human Tooth Development
Tooth enamel secreted by ameloblasts is the hardest material in the human body, acting as a shield protecting the teeth. However, the enamel is gradually damaged or partially lost in over 90% of adults and cannot be regenerated due to a lack of ameloblasts in erupted teeth. Here we use sci-RNA-seq to establish a spatiotemporal single-cell atlas for the developing human tooth and identify regulatory mechanisms controlling the differentiation process of human ameloblasts. We reveal key signaling pathways involved between the support cells and ameloblasts during fetal development and recapitulate those findings in a novel human ameloblast in vitro differentiation from iPSCs. We furthermore develop a mineralizing enamel organ-like 3D organoid system. These studies pave the way for future regenerative dentistry and therapies toward genetic diseases affecting enamel formation.
Open AccessHuman iPSC Derived Enamel Organoid Guided by Single-Cell Atlas of Human Tooth Development
Tooth enamel secreted by ameloblasts is the hardest material in the human body, acting as a shield protecting the teeth. However, the enamel is gradually damaged or partially lost in over 90% of adults and cannot be regenerated due to a lack of ameloblasts in erupted teeth. Here we use sci-RNA-seq to establish a spatiotemporal single-cell atlas for the developing human tooth and identify regulatory mechanisms controlling the differentiation process of human ameloblasts. We reveal key signaling pathways involved between the support cells and ameloblasts during fetal development and recapitulate those findings in a novel human ameloblast in vitro differentiation from iPSCs. We furthermore develop a mineralizing enamel organ-like 3D organoid system. These studies pave the way for future regenerative dentistry and therapies toward genetic diseases affecting enamel formation.
- Open Access
Temporal dynamics of metabolic acquisition in grafted engineered human liver tissue
Liver disease affects millions globally and end-stage liver failure is only cured by organ transplant. Unfortunately, there is a growing shortage of donor organs and disparities in equitable access to transplants among different populations. Less than 10% of global transplantation needs are currently met, highlighting the demand for alternative therapies. Engineered liver tissue grafts that supplement organ function could address these demands. While engineered liver tissues built from human hepatocytes, endothelial cells, and fibroblasts encased in hydrogel have been successfully engrafted in rodent models previously, the extent to which these tissues express human liver metabolic genes and proteins remains unknown. Here, we built engineered human liver tissues and characterized their engraftment, expansion, and metabolic phenotype at sequential stages post-implantation by RNA sequencing, histology, and host serology. Expression of metabolic genes was observed at weeks 1-2, followed by cellular organization into hepatic cords by weeks 4-9.5. Furthermore, grafted engineered tissues exhibited progressive spatially restricted expression of critical functional proteins known to be zonated in the native human liver. To our knowledge, this is the first report of engineered human liver tissue zonation after implantation in vivo, which could have important translational implications for this field.
Open AccessTemporal dynamics of metabolic acquisition in grafted engineered human liver tissue
Liver disease affects millions globally and end-stage liver failure is only cured by organ transplant. Unfortunately, there is a growing shortage of donor organs and disparities in equitable access to transplants among different populations. Less than 10% of global transplantation needs are currently met, highlighting the demand for alternative therapies. Engineered liver tissue grafts that supplement organ function could address these demands. While engineered liver tissues built from human hepatocytes, endothelial cells, and fibroblasts encased in hydrogel have been successfully engrafted in rodent models previously, the extent to which these tissues express human liver metabolic genes and proteins remains unknown. Here, we built engineered human liver tissues and characterized their engraftment, expansion, and metabolic phenotype at sequential stages post-implantation by RNA sequencing, histology, and host serology. Expression of metabolic genes was observed at weeks 1-2, followed by cellular organization into hepatic cords by weeks 4-9.5. Furthermore, grafted engineered tissues exhibited progressive spatially restricted expression of critical functional proteins known to be zonated in the native human liver. To our knowledge, this is the first report of engineered human liver tissue zonation after implantation in vivo, which could have important translational implications for this field.
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 32 (11) , 2697-2713
Podocyte Aging: Why and How Getting Old Matters
The effects of healthy aging on the kidney, and how these effects intersect with superimposed diseases, are highly relevant in the context of the population’s increasing longevity. Age-associated changes to podocytes, which are terminally differentiated glomerular epithelial cells, adversely affect kidney health. This review discusses the molecular and cellular mechanisms underlying podocyte aging, how these mechanisms might be augmented by disease in the aged kidney, and approaches to mitigate progressive damage to podocytes. Furthermore, we address how biologic pathways such as those associated with cellular growth confound aging in humans and rodents.
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 32 (11) , 2697-2713
Podocyte Aging: Why and How Getting Old Matters
The effects of healthy aging on the kidney, and how these effects intersect with superimposed diseases, are highly relevant in the context of the population’s increasing longevity. Age-associated changes to podocytes, which are terminally differentiated glomerular epithelial cells, adversely affect kidney health. This review discusses the molecular and cellular mechanisms underlying podocyte aging, how these mechanisms might be augmented by disease in the aged kidney, and approaches to mitigate progressive damage to podocytes. Furthermore, we address how biologic pathways such as those associated with cellular growth confound aging in humans and rodents.
- 7 July 2021
- Published by Springer Nature in GeroScience
- Vol. 43 (5) , 2161-2165
University of Washington Nathan Shock Center: innovation to advance aging research
The University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging provides leadership and resources to support the geroscience community locally, nationally, and internationally. Services are provided through our Resource Cores and funds are available annually to support pilot projects by external investigators. Aging-related studies involving proteomics, metabolomics, invertebrate model organisms, and bioinformatics/artificial intelligence are supported by our Cores. The UW Nathan Shock Center also serves as the administrative home for a Geropathology Research Resource. In addition, the Center works in conjunction with the University of Washington Healthy Aging and Longevity Research Institute to organize and support an annual Seminar Series in the Biology of Aging, an annual 1-day Geroscience Symposium, didactic training for the Biological Mechanisms of Healthy Aging Training Program, and other strategic initiatives. Our Center also supports the American Aging Association Annual Meeting, and we have recently partnered with the American Aging Association and the JAX Aging Center to create a set of video lectures on select topics in geroscience as part of the AGE Presents Video Lecture Series.
- 7 July 2021
- Published by Springer Nature in GeroScience
- Vol. 43 (5) , 2161-2165
University of Washington Nathan Shock Center: innovation to advance aging research
The University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging provides leadership and resources to support the geroscience community locally, nationally, and internationally. Services are provided through our Resource Cores and funds are available annually to support pilot projects by external investigators. Aging-related studies involving proteomics, metabolomics, invertebrate model organisms, and bioinformatics/artificial intelligence are supported by our Cores. The UW Nathan Shock Center also serves as the administrative home for a Geropathology Research Resource. In addition, the Center works in conjunction with the University of Washington Healthy Aging and Longevity Research Institute to organize and support an annual Seminar Series in the Biology of Aging, an annual 1-day Geroscience Symposium, didactic training for the Biological Mechanisms of Healthy Aging Training Program, and other strategic initiatives. Our Center also supports the American Aging Association Annual Meeting, and we have recently partnered with the American Aging Association and the JAX Aging Center to create a set of video lectures on select topics in geroscience as part of the AGE Presents Video Lecture Series.
- Open Access
Identifying neuron subtype-specific metabolic network changes in single cell transcriptomics of Alzheimer’s Disease using perturb-Met
Metabolic aberrations are a prominent feature of Alzheimer’s Disease (AD). Different neuronal subtypes have selective vulnerability in AD. Despite the recent advance of single cell and single nucleus RNA-seq of AD brains, genome-scale metabolic network changes in neuronal subtypes have not been systematically studied with detail. To bridge this knowledge gap, I developed a computational method called perturb-Met that can uncover transcriptional dysregulation centered at hundreds of metabolites in a metabolic network. perturb-Met successfully recapitulated known glycolysis, cholesterol, and other metabolic defects in APOE4-neurons and microglia, many of which are missed by current methods. Applying perturb-Met on AD snRNA-seq data, I revealed that the four neuronal subtypes in the entorhinal cortex shows subtype-specific metabolic changes, namely mitochondrial complex I metabolism, ganglioside metabolism, galactose and heparan sulfate metabolism, as well as glucose and lipid metabolism, respectively. perturb-Met also revealed significant changes in protein glycosylation in the neuron subtype specifically found in AD brains. These subtype-specific metabolic changes may potentially underlie their selective vulnerability in AD. perturb-Met is a valuable tool to discover potential metabolic network changes in many other single cell or bulk transcriptomic studies.
Open AccessIdentifying neuron subtype-specific metabolic network changes in single cell transcriptomics of Alzheimer’s Disease using perturb-Met
Metabolic aberrations are a prominent feature of Alzheimer’s Disease (AD). Different neuronal subtypes have selective vulnerability in AD. Despite the recent advance of single cell and single nucleus RNA-seq of AD brains, genome-scale metabolic network changes in neuronal subtypes have not been systematically studied with detail. To bridge this knowledge gap, I developed a computational method called perturb-Met that can uncover transcriptional dysregulation centered at hundreds of metabolites in a metabolic network. perturb-Met successfully recapitulated known glycolysis, cholesterol, and other metabolic defects in APOE4-neurons and microglia, many of which are missed by current methods. Applying perturb-Met on AD snRNA-seq data, I revealed that the four neuronal subtypes in the entorhinal cortex shows subtype-specific metabolic changes, namely mitochondrial complex I metabolism, ganglioside metabolism, galactose and heparan sulfate metabolism, as well as glucose and lipid metabolism, respectively. perturb-Met also revealed significant changes in protein glycosylation in the neuron subtype specifically found in AD brains. These subtype-specific metabolic changes may potentially underlie their selective vulnerability in AD. perturb-Met is a valuable tool to discover potential metabolic network changes in many other single cell or bulk transcriptomic studies.
- 25 June 2020
- Published by Elsevier in Kidney International
- Vol. 98 (5) , 1160-1173
Global transcriptomic changes occur in aged mouse podocytes
- 25 June 2020
- Published by Elsevier in Kidney International
- Vol. 98 (5) , 1160-1173
Global transcriptomic changes occur in aged mouse podocytes
- Open Access
- 26 February 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities
Spatial heterogeneity is a fundamental feature of the tumor microenvironment (TME), and tackling spatial heterogeneity in neoplastic metabolic aberrations is critical for tumor treatment. Genome-scale metabolic network models have been used successfully to simulate cancer metabolic networks. However, most models use bulk gene expression data of entire tumor biopsies, ignoring spatial heterogeneity in the TME. To account for spatial heterogeneity, we performed spatially-resolved metabolic network modeling of the prostate cancer microenvironment. We discovered novel malignant-cell-specific metabolic vulnerabilities targetable by small molecule compounds. We predicted that inhibiting the fatty acid desaturase SCD1 may selectively kill cancer cells based on our discovery of spatial separation of fatty acid synthesis and desaturation. We also uncovered higher prostaglandin metabolic gene expression in the tumor, relative to the surrounding tissue. Therefore, we predicted that inhibiting the prostaglandin transporter SLCO2A1 may selectively kill cancer cells. Importantly, SCD1 and SLCO2A1 have been previously shown to be potently and selectively inhibited by compounds such as CAY10566 and suramin, respectively. We also uncovered cancer-selective metabolic liabilities in central carbon, amino acid, and lipid metabolism. Our novel cancer-specific predictions provide new opportunities to develop selective drug targets for prostate cancer and other cancers where spatial transcriptomics datasets are available.
- 26 February 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Open AccessSpatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities
Spatial heterogeneity is a fundamental feature of the tumor microenvironment (TME), and tackling spatial heterogeneity in neoplastic metabolic aberrations is critical for tumor treatment. Genome-scale metabolic network models have been used successfully to simulate cancer metabolic networks. However, most models use bulk gene expression data of entire tumor biopsies, ignoring spatial heterogeneity in the TME. To account for spatial heterogeneity, we performed spatially-resolved metabolic network modeling of the prostate cancer microenvironment. We discovered novel malignant-cell-specific metabolic vulnerabilities targetable by small molecule compounds. We predicted that inhibiting the fatty acid desaturase SCD1 may selectively kill cancer cells based on our discovery of spatial separation of fatty acid synthesis and desaturation. We also uncovered higher prostaglandin metabolic gene expression in the tumor, relative to the surrounding tissue. Therefore, we predicted that inhibiting the prostaglandin transporter SLCO2A1 may selectively kill cancer cells. Importantly, SCD1 and SLCO2A1 have been previously shown to be potently and selectively inhibited by compounds such as CAY10566 and suramin, respectively. We also uncovered cancer-selective metabolic liabilities in central carbon, amino acid, and lipid metabolism. Our novel cancer-specific predictions provide new opportunities to develop selective drug targets for prostate cancer and other cancers where spatial transcriptomics datasets are available.
- Open Access
- 2 February 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
talklr uncovers ligand-receptor mediated intercellular crosstalk
Single cell RNA-seq measures the transcriptomes of many cell types across diverse conditions. However, an emerging challenge is to uncover how different cell types communicate with each other to maintain tissue homeostasis, and how inter-cellular communications are perturbed in diseases. To address this problem, we developed talklr, an information theory-based approach to uncover potential ligand-receptor interactions involved in tissue homeostasis and diseases. Compared to existing approaches that analyze changes in each gene in each cell type separately, talklr uses a holistic approach to simultaneously consider expression changes in both ligands and receptors across multiple cell types and conditions. talklr outperformed existing approaches in identifying ligand-receptor interactions, including those known to be important for tissue-specific functions and diseases across diverse datasets. talklr can reveal important signaling events in many biological problems in an unbiased way, and will be a valuable tool in single cell RNA-seq analysis. talklr is available as both an interactive website and an R package.
- 2 February 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
Open Accesstalklr uncovers ligand-receptor mediated intercellular crosstalk
Single cell RNA-seq measures the transcriptomes of many cell types across diverse conditions. However, an emerging challenge is to uncover how different cell types communicate with each other to maintain tissue homeostasis, and how inter-cellular communications are perturbed in diseases. To address this problem, we developed talklr, an information theory-based approach to uncover potential ligand-receptor interactions involved in tissue homeostasis and diseases. Compared to existing approaches that analyze changes in each gene in each cell type separately, talklr uses a holistic approach to simultaneously consider expression changes in both ligands and receptors across multiple cell types and conditions. talklr outperformed existing approaches in identifying ligand-receptor interactions, including those known to be important for tissue-specific functions and diseases across diverse datasets. talklr can reveal important signaling events in many biological problems in an unbiased way, and will be a valuable tool in single cell RNA-seq analysis. talklr is available as both an interactive website and an R package.